Global Markets
Beyond the peak: Catalent prepped for two-third cut in COVID revenues
Global MarketsBeyond the peak: Catalent prepped for two-third cut in COVID revenuesBeyond the peak: Catalent prepped for two-third cut in COVID revenues
Increased CGT, drug product and substance demand will offset the decline in COVID-19 revenues in FY 2023, says CDMO Catalent.